The utility of ductal lavage in breast cancer detection and risk assessment

por Domchek, Susan M
Publicado 2002

Variation in breast cancer risk in BRCA1 and BRCA2 mutation carriers

por Rebbeck, Timothy R, Domchek, Susan M
Publicado 2008

Breast cancer in young women

por Gabriel, Courtney A, Domchek, Susan M
Publicado 2010

Meta-analysis of Risk Reduction Estimates Associated With Risk-Reducing Salpingo-oophorectomy in BRCA1 or BRCA2 Mutation Carriers

por Rebbeck, Timothy R., Kauff, Noah D., Domchek, Susan M.
Publicado 2009

Clinical Characteristics of Patients With Pancreatic Cancer and Pathogenic ATM Alterations

por Hannan, Zain, Yu, Shun, Domchek, Susan, Mamtani, Ronac, Reiss, Kim A
Publicado 2021

Reaching beyond family history as inclusion criteria for pancreatic cancer surveillance in high-risk populations

por Wang, Louise, Domchek, Susan M., Kochman, Michael L., Katona, Bryson W.
Publicado 2022

Analysis of BRCA1- and BRCA2-Related Pancreatic Cancer and Survival

por Boursi, Ben, Wileyto, E. Paul, Mamtani, Ronac, Domchek, Susan M., Golan, Talia, Hood, Ryan, Reiss, Kim A.
Publicado 2023

Associations between breast density and a panel of single nucleotide polymorphisms linked to breast cancer risk: a cohort study with digital mammography

por Keller, Brad M, McCarthy, Anne Marie, Chen, Jinbo, Armstrong, Katrina, Conant, Emily F, Domchek, Susan M, Kontos, Despina
Publicado 2015

Quantitative assessment of background parenchymal enhancement in breast MRI predicts response to risk-reducing salpingo-oophorectomy: preliminary evaluation in a cohort of BRCA1/2...

por Wu, Shandong, Weinstein, Susan P, DeLeo, Michael J, Conant, Emily F, Chen, Jinbo, Domchek, Susan M, Kontos, Despina
Publicado 2015

Erratum to: Quantitative assessment of background parenchymal enhancement in breast MRI predicts response to risk-reducing salpingo-oophorectomy: preliminary evaluation in a cohort...

por Wu, Shandong, Weinstein, Susan P., DeLeo, Michael J., Conant, Emily F., Chen, Jinbo, Domchek, Susan M., Kontos, Despina
Publicado 2015

The use of the Gail model, body mass index and SNPs to predict breast cancer among women with abnormal (BI-RADS 4) mammograms

por McCarthy, Anne Marie, Keller, Brad, Kontos, Despina, Boghossian, Leigh, McGuire, Erin, Bristol, Mirar, Chen, Jinbo, Domchek, Susan, Armstrong, Katrina
Publicado 2015

Medical oncologists’ willingness to participate in bundled payment programs

por Murciano-Goroff, Yonina R., McCarthy, Anne Marie, Bristol, Mirar N., Domchek, Susan M., Groeneveld, Peter W., Motanya, U. Nkiru, Armstrong, Katrina
Publicado 2018

DCIS in BRCA1 and BRCA2 mutation carriers: prevalence, phenotype, and expression of oncodrivers C-MET and HER3

por Yang, Rachel L., Mick, Rosemarie, Lee, Kathreen, Graves, Holly L., Nathanson, Katherine L., Domchek, Susan M., Kelz, Rachel R., Zhang, Paul J., Czerniecki, Brian J.
Publicado 2015

Evaluation of a web‐based weight loss intervention in overweight cancer survivors aged 50 years and younger

por Lynch, S. M., Stricker, C. T., Brown, J. C., Berardi, J. M., Vaughn, D., Domchek, S., Filseth, S., Branas, A., Weiss‐Trainor, E., Schmitz, K. H., Sarwer, D. B.
Publicado 2017

OlympiAD final overall survival and tolerability results: Olaparib versus chemotherapy treatment of physician’s choice in patients with a germline BRCA mutation and HER2-negative m...

por Robson, M E, Tung, N, Conte, P, Im, S -A, Senkus, E, Xu, B, Masuda, N, Delaloge, S, Li, W, Armstrong, A, Wu, W, Goessl, C, Runswick, S, Domchek, S M
Publicado 2019

Platinum response characteristics of patients with pancreatic ductal adenocarcinoma and a germline BRCA1, BRCA2 or PALB2 mutation

por Wattenberg, Max M., Asch, Daniella, Yu, Shun, O’Dwyer, Peter J., Domchek, Susan M., Nathanson, Katherine L., Rosen, Mark A., Beatty, Gregory L., Siegelman, Evan S., Reiss, Kim A.
Publicado 2019

Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers

por Metcalfe, K, Gershman, S, Lynch, H T, Ghadirian, P, Tung, N, Kim-Sing, C, Olopade, O I, Domchek, S, McLennan, J, Eisen, A, Foulkes, W D, Rosen, B, Sun, P, Narod, S A
Publicado 2011

Conflicting Interpretation of Genetic Variants and Cancer Risk by Commercial Laboratories as Assessed by the Prospective Registry of Multiplex Testing

por Balmaña, Judith, Digiovanni, Laura, Gaddam, Pragna, Walsh, Michael F., Joseph, Vijai, Stadler, Zsofia K., Nathanson, Katherine L., Garber, Judy E., Couch, Fergus J., Offit, Kenneth, Robson, Mark E., Domchek, Susan M.
Publicado 2016

Development and Validation of a Clinical Polygenic Risk Score to Predict Breast Cancer Risk

por Hughes, Elisha, Tshiaba, Placede, Gallagher, Shannon, Wagner, Susanne, Judkins, Thaddeus, Roa, Benjamin, Rosenthal, Eric, Domchek, Susan, Garber, Judy, Lancaster, Johnathan, Weitzel, Jeffrey, Kurian, Allison W., Lanchbury, Jerry S., Gutin, Alexander, Robson, Mark
Publicado 2020

BRCA1/2 Mutations and Cardiovascular Function in Breast Cancer Survivors

por Demissei, Biniyam G., Lv, WenJian, Wilcox, Nicholas S., Sheline, Karyn, Smith, Amanda M., Sturgeon, Kathleen M., McDermott-Roe, Chris, Musunuru, Kiran, Lefebvre, Bénédicte, Domchek, Susan M., Shah, Payal, Ky, Bonnie
Publicado 2022